Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 EUR | +0.82% | -4.65% | +2.07% |
Apr. 22 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
Apr. 11 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |